Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
I can help you #myhealthjourney #myglp1journey #migrainerelief 4 Weeks On A GLP1 I have to say my only regret is that I didnt do this for myself sooner #glp1diary #glp1s #zepbound #zepbound #glp1 #glp1community #week5 37 weeks on my GLP-1 journey Down 59 lbs (even with 56 weeks off + a stall the last couple months)
Ferreira-Cravo M, Moreira DC, Hermes-Lima M
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, producing wide-ranging effects on appetite, digestion, and metabolism